search
Back to results

Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked (XLMR)

Primary Purpose

X-linked Mental Retardation

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Neuropsychological, cognitive and behavioral assessment
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for X-linked Mental Retardation focused on measuring phenotype, X-linked mental retardation, neuronal networks, cognitive processes

Eligibility Criteria

2 Years - 60 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age : from 2 to 60 years old
  • Having a pathogenic mutation of one of the X chromosome genes associated with :

    • For boys : mental retardation (IQ<70), and/or developmental delay (DQ<70) and/or pervasive developmental disorder (autism, Asperger…)
    • For girls : mental retardation (IQ<70), and/or developmental delay (DQ<70) and/or pervasive developmental disorder (autism, Asperger…) and/or specific learning disabilities

Exclusion Criteria:

  • patient or parents refusal to participate in the study
  • genetic polymorphism in a X chromosome gene involved in mental retardation but not considered as pathogenic
  • person refusing to be informed if an abnormality would be discovered during medical examination

Sites / Locations

  • Groupement Hospitalier Est - Hôpital Femme Mère Enfant - Service de neurologie pédiatriqueRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

X-linked Mental retardation

Control Group

Arm Description

This is an observational study which will allow to precisely describe the phenotype associated to each X-linked mental retardation gene.

This group will be compared to X-linked mental retardation group in order to obtain a baseline on some cognitive tests.

Outcomes

Primary Outcome Measures

Clinical phenotyping of neurodevelopment: acquisition age of early developmental skills (motor and language), and the adaptive skills profile (Vineland adaptive behavioral scale)
The primary outcome measure is composite and includes acquisition age of early developmental skills (motor and language), and the adaptive skills profile (Vineland adaptive behavioral scale). The Vineland adaptive behavioral scale performed during a semi-structured interview of the parents of the patient, will assess the adaptive behavior profile of the patient (including communication, daily living skills, socialization, motricity and the global adaptive score).

Secondary Outcome Measures

Intellectual functioning assessment (Wechsler scale)
The Intellectual Quotient of the patient will be assessed using a Wechsler scale, adapted to the age of the patient. For patients younger than 3 years or too severely impaired to perform a Wechsler scale, the Brunet Lézine scale will be used.
Raven's Progressive matrices
The Raven's Progressives matrices test will allow to assess the non-verbal reasoning mental age of the patient
Peabody Picture Vocabulary Test Revised
The Peabody Picture Vocabulary Test Revised will allow to determine the Vocabulary age (receptive language) of the patient.
Edinburgh handedness test
The Edinburgh handedness test will assess the handedness of the patients.
Birth parameters: weight, height and head circumference and APGAR score
The birth parameters include weight, height and head circumference at birth, as well as the initial cardiac and pulmonary adaptation (APGAR score).
Nisonger child behavior rating form
The Nisonger child behavior rating form will allow the assessment of behavior disorders including: conduct disorders, anxiety, hyperactivity, automutilation/stereotyped behavior, self-isolation/rituals, sensitivity/susceptibility.
Caregiver Burden Inventory Modified
The Caregiver Burden Inventory Modified will allow the assessment of the impact of mental retardation on the primary caregiver within the family.
Analogical visual reasoning task (behavior assessment)
This paradigm (HCL/CNRS patented), appropriate for mentally retarded patients provides an objective and quantitative assessment of visual analogical reasoning and cognitive inhibition.
Analogical visual reasoning task (eye-tracking assessment)
The eye-tracking analysis of this paradigm (HCL/CNRS patented) made it possible to identify the strategy used by participants to solve the task. Mentally Retarded patients are not able to explicitly explain the strategy they used to solve the task, but with eye-tracking analysis, we can understand how they performed the task, which is crucial information in order to help them improve their performance through remediation strategies.
Kinematic analysis of a grasping movement
This kinematic analysis of a grasping movement will allow us to study the effect of the orientation (+56°or -56°) and the type of pinch (thumb-index, thumb-middle finger and thumb-annular) on the movement duration and both the transport component (wrist acceleration and velocity peaks, latencies and amplitudes) and the grasp component (maximum grip aperture latency and amplitude and opposition axis).
Structural neuroimaging by MRI
Structural brain MRI analysis will determine if a specific morphological neuroanatomical pattern can be found for each X-linked mental retardation gene.
Functional neuroimaging by MRI
Functional brain MRI analysis will determine if patients with X-linked mental retardation have a specific functional neuroanatomical pattern associated to the reasoning task.
School curriculum: age and type of shool
The school curriculum will include the age at school entrance, and the type of school the child went to.

Full Information

First Posted
June 29, 2016
Last Updated
July 11, 2017
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT02854956
Brief Title
Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked
Acronym
XLMR
Official Title
Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Unknown status
Study Start Date
April 2011 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
March 31, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
X-linked Mental retardation (XLMR) represent 10% of the causes of mental retardation with a prevalence in both sexes around 1/296, i.e. 3.3 / 1000 births (Opitz et al., 1986). This heterogeneous group of XLMR includes dozens of rare diseases, some of them affecting only a few patients. Molecular diagnosis is currently available in France for 25 XLMR genes, within the national network of XLMR molecular diagnosis. However, whereas some syndromes such as Fragile X syndrome, are now well clinically defined, this is not the case for recently identified syndromes for which very few data is available, preventing clinicians to focus molecular diagnosis on a specific gene. Therefore, this study aims to : Achieve a description of the clinical phenotype specific to each XLMR gene (Phase 1 of the study, n=200) Characterize the cognitive learning mechanisms and dysfunctional neural networks involved (Phase 2 of the study, n=75, i.e. 5 groups of 15 patients with a mutation in the same gene). These two elements constitute key steps to develop appropriate rehabilitation strategies and targeted pharmacological therapies. Moreover, the impact of mental retardation on the primary caregiver within the family and the induced burden in terms of psycho-social, organizational and economic burden will also be assessed. These elements, directly related to the patient's environment, are very important to characterize in order to better understand the consequences of each gene mutation (Phase 3 of the study, n=283). For example, it is necessary to better understand the impact of Fragile X syndrome in terms of capacity and behavior, lifestyle, and health care needs of the patients While advancing knowledge allows to consider innovative therapeutics, the implementation of these therapeutics and assessment of their impact on the patients' life trajectory, require precise characterization of the population to be treated in medico socioeconomic terms.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
X-linked Mental Retardation
Keywords
phenotype, X-linked mental retardation, neuronal networks, cognitive processes

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
573 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
X-linked Mental retardation
Arm Type
Other
Arm Description
This is an observational study which will allow to precisely describe the phenotype associated to each X-linked mental retardation gene.
Arm Title
Control Group
Arm Type
Other
Arm Description
This group will be compared to X-linked mental retardation group in order to obtain a baseline on some cognitive tests.
Intervention Type
Behavioral
Intervention Name(s)
Neuropsychological, cognitive and behavioral assessment
Intervention Description
The assessment includes mainly : The Raven's Progressives matrices test which allow to assess the non-verbal reasoning mental age of the patient The Wechsler scale or Brunet Lézine scale which allow to assess The Intellectual Quotient The Peabody Picture Vocabulary Test Revised which allow to determine the Vocabulary age (receptive language). The Vineland adaptive behavioral scale which allow to assess the adaptive behavior The Nisonger child behavior rating form which allow to assess the behavior disorders Analogical visual reasoning task (eye-tracking assessment and behavior assessment) which allow to identify the strategy used to solve the task and provides an objective and quantitative assessment of visual analogical reasoning and cognitive inhibition. Kinematic analysis of a grasping movement which allow to study the effect of the orientation and the type of pinch on the movement duration and both the transport component and the grasp component.
Primary Outcome Measure Information:
Title
Clinical phenotyping of neurodevelopment: acquisition age of early developmental skills (motor and language), and the adaptive skills profile (Vineland adaptive behavioral scale)
Description
The primary outcome measure is composite and includes acquisition age of early developmental skills (motor and language), and the adaptive skills profile (Vineland adaptive behavioral scale). The Vineland adaptive behavioral scale performed during a semi-structured interview of the parents of the patient, will assess the adaptive behavior profile of the patient (including communication, daily living skills, socialization, motricity and the global adaptive score).
Time Frame
at inclusion (Day 1)
Secondary Outcome Measure Information:
Title
Intellectual functioning assessment (Wechsler scale)
Description
The Intellectual Quotient of the patient will be assessed using a Wechsler scale, adapted to the age of the patient. For patients younger than 3 years or too severely impaired to perform a Wechsler scale, the Brunet Lézine scale will be used.
Time Frame
at inclusion (Day 1)
Title
Raven's Progressive matrices
Description
The Raven's Progressives matrices test will allow to assess the non-verbal reasoning mental age of the patient
Time Frame
at inclusion (Day 1)
Title
Peabody Picture Vocabulary Test Revised
Description
The Peabody Picture Vocabulary Test Revised will allow to determine the Vocabulary age (receptive language) of the patient.
Time Frame
at inclusion (Day 1)
Title
Edinburgh handedness test
Description
The Edinburgh handedness test will assess the handedness of the patients.
Time Frame
at inclusion (Day 1)
Title
Birth parameters: weight, height and head circumference and APGAR score
Description
The birth parameters include weight, height and head circumference at birth, as well as the initial cardiac and pulmonary adaptation (APGAR score).
Time Frame
at inclusion (Day 1)
Title
Nisonger child behavior rating form
Description
The Nisonger child behavior rating form will allow the assessment of behavior disorders including: conduct disorders, anxiety, hyperactivity, automutilation/stereotyped behavior, self-isolation/rituals, sensitivity/susceptibility.
Time Frame
at inclusion (Day 1)
Title
Caregiver Burden Inventory Modified
Description
The Caregiver Burden Inventory Modified will allow the assessment of the impact of mental retardation on the primary caregiver within the family.
Time Frame
at inclusion (Day 1)
Title
Analogical visual reasoning task (behavior assessment)
Description
This paradigm (HCL/CNRS patented), appropriate for mentally retarded patients provides an objective and quantitative assessment of visual analogical reasoning and cognitive inhibition.
Time Frame
at inclusion (Day 1)
Title
Analogical visual reasoning task (eye-tracking assessment)
Description
The eye-tracking analysis of this paradigm (HCL/CNRS patented) made it possible to identify the strategy used by participants to solve the task. Mentally Retarded patients are not able to explicitly explain the strategy they used to solve the task, but with eye-tracking analysis, we can understand how they performed the task, which is crucial information in order to help them improve their performance through remediation strategies.
Time Frame
at inclusion (Day 1)
Title
Kinematic analysis of a grasping movement
Description
This kinematic analysis of a grasping movement will allow us to study the effect of the orientation (+56°or -56°) and the type of pinch (thumb-index, thumb-middle finger and thumb-annular) on the movement duration and both the transport component (wrist acceleration and velocity peaks, latencies and amplitudes) and the grasp component (maximum grip aperture latency and amplitude and opposition axis).
Time Frame
at inclusion (Day 1)
Title
Structural neuroimaging by MRI
Description
Structural brain MRI analysis will determine if a specific morphological neuroanatomical pattern can be found for each X-linked mental retardation gene.
Time Frame
at inclusion (Day 1)
Title
Functional neuroimaging by MRI
Description
Functional brain MRI analysis will determine if patients with X-linked mental retardation have a specific functional neuroanatomical pattern associated to the reasoning task.
Time Frame
at inclusion (Day 1)
Title
School curriculum: age and type of shool
Description
The school curriculum will include the age at school entrance, and the type of school the child went to.
Time Frame
at inclusion (Day 1)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age : from 2 to 60 years old Having a pathogenic mutation of one of the X chromosome genes associated with : For boys : mental retardation (IQ<70), and/or developmental delay (DQ<70) and/or pervasive developmental disorder (autism, Asperger…) For girls : mental retardation (IQ<70), and/or developmental delay (DQ<70) and/or pervasive developmental disorder (autism, Asperger…) and/or specific learning disabilities Exclusion Criteria: patient or parents refusal to participate in the study genetic polymorphism in a X chromosome gene involved in mental retardation but not considered as pathogenic person refusing to be informed if an abnormality would be discovered during medical examination
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vincent DESPORTES, Pr
Phone
(0)4 27 85 67 61
Ext
+33
Email
vincent.desportes@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Sonia GALLETTI
Phone
(0)4 27 85 77 39
Ext
+33
Email
sonia.galletti@chu-lyon.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vincent DESPORTES, Pr
Organizational Affiliation
Groupement Hospitalier Est - Hôpital Femme Mère Enfant - Service de neurologie pédiatrique
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupement Hospitalier Est - Hôpital Femme Mère Enfant - Service de neurologie pédiatrique
City
Bron
ZIP/Postal Code
69500
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vincent DESPORTES, Pr
Phone
(0)4 27 85 67 61
Ext
+33
Email
vincent.desportes@chu-lyon.fr
First Name & Middle Initial & Last Name & Degree
Sonia GALLETTI
Phone
(0)4 27 85 77 39
Ext
+33
Email
sonia.galletti@chu-lyon.fr

12. IPD Sharing Statement

Learn more about this trial

Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked

We'll reach out to this number within 24 hrs